Company Filing History:
Years Active: 1997-1999
Title: The Innovative Contributions of Sandra M. Butler
Introduction
Sandra M. Butler is a notable inventor based in Laurel, MD (US), recognized for her significant contributions to the field of biomedical research. With a total of 5 patents, her work primarily focuses on cancer diagnostics and therapies, showcasing her commitment to advancing medical science.
Latest Patents
One of her latest patents is related to tumor-associated epitopes. This invention pertains to the epitopes that monoclonal antibodies 88BV59 and 16.88 react with. These antibodies were developed from B-cell lines derived from cancer patients who were actively immunized with autologous tumor antigens. Both epitopes are found on the same antigen in tumor tissue, and they hold potential for use in diagnostic procedures and therapies for human cancers. Another significant patent involves antibodies to apolipoprotein(a). This invention relates to peptides that are immunoreactive with anti-apolipoprotein(a) antibodies. These peptides can be utilized in raising monoclonal and polyclonal antibodies, as well as in immunoassays and nucleic acid methodologies.
Career Highlights
Throughout her career, Sandra has worked with prominent companies such as Per Immune Holdings, Inc. and Akzo Nobel N.V. Her experience in these organizations has contributed to her expertise in the field of immunology and cancer research.
Collaborations
Sandra has collaborated with notable colleagues, including W. C. Taddei-Peters and Nicholas Pomato. These partnerships have further enriched her research and innovation efforts.
Conclusion
Sandra M. Butler's contributions to the field of biomedical research through her patents and collaborations highlight her role as a leading inventor in cancer diagnostics and therapies. Her work continues to inspire advancements in medical science.